Vanguard Personalized Indexing Management
LIMN

Vanguard Personalized Indexing Management’s Liminatus Pharma LIMN Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio LIMN Stock Details LIMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45K Sell
263
-431
-62% -$3.72K ﹤0.01% 2242
2026
Q1 		$5.97K Buy
+694
New +$18.5K ﹤0.01% 2164

Other funds holding LIMN

CCA
Cygnus Capital Advisors Atlanta, Georgia $147M AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Personalized Indexing Management's LIMN Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Liminatus Pharma (LIMN) stake by 62% in Q2 2026, selling an estimated $3.72K and leaving 263 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2242.

Vanguard Personalized Indexing Management first reported a position in LIMN in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.97K in Q1 2026. 14 funds tracked by Wall St. Rank hold LIMN as of Q2 2026.

  • Vanguard Personalized Indexing Management held 263 shares of Liminatus Pharma worth $1.45K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 431 Liminatus Pharma shares in Q2 2026, an estimated $3.72K.
  • Liminatus Pharma made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2242 holding.
  • Vanguard Personalized Indexing Management first reported a position in Liminatus Pharma in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Personalized Indexing Management's Liminatus Pharma position peaked at $5.97K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Liminatus Pharma as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.